Arcellx Inc ACLX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
49.74quote price arrow down-2.99 (-5.67%)
Volume
880,127
52 week range
30.74 - 75.10
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close49.74
  • 52 Week High75.10
  • 52 Week High Date03/07/24
  • 52 Week Low30.74
  • 52 Week Low Date07/05/23

Key Stats

  • Market Cap2.651B
  • Shares Out53.29M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change-10.38

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close49.74
  • 52 Week High75.10
  • 52 Week High Date03/07/24
  • 52 Week Low30.74
  • 52 Week Low Date07/05/23
  • Market Cap2.651B
  • Shares Out53.29M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change-10.38

RATIOS/PROFITABILITY

  • EPS (TTM)-1.04
  • P/E (TTM)-47.89
  • Fwd P/E (NTM)-25.87
  • EBITDA (TTM)-87.84M
  • ROE (TTM)-20.48%
  • Revenue (TTM)110.319M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-64.08%
  • Debt To Equity (MRQ)8.09%

EVENTS

  • Earnings Date08/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arcellx Inc

 

Profile

MORE
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage...
Rami Elghandour
Chairman of the Board, President, Chief Executive Officer
Michelle Gilson
Chief Financial Officer
Address
800 Bridge Parkway
Redwood City, CA
94065
United States

Top Peers

SYMBOLLASTCHG%CHG
RYTM
Rhythm Pharmaceuticals Inc
39.14+0.64+1.66%
MRUS
Merus NV
44.52-0.60-1.33%
CLDX
Celldex Therapeutics Inc
39.92-1.14-2.78%
MOR
MorphoSys AG
18.00+0.13+0.73%
ARWR
Arrowhead Pharmaceuticals Inc
22.08-2.64-10.68%